Candidate Information Title Medical Affairs Field Target Location US-NY-East Amherst	20,000+ Fresh Resumes Monthly     View Phone Numbers     Receive Resume E-mail Alerts     Post Jobs Free     Link your Free Jobs Page     ... and much more Register on Jobvertise Free
Search 2 million Resumes Keywords: City or Zip:	Related Resumes Regulatory Affairs- Medical Affairs Executive East Amherst, NY Medical Device Health Care Brockport, NY Medical Assistant Call Center Buffalo, NY Medical Records Office Manager Attica, NY United States Medical Receptionist Holley, NY Registered Nurse Medical Center Lancaster, NY Medical Billing Veterinary Technician Buffalo, NY

PROFILEAccomplished PharmD BCPS professional, specializing in ophthalmology, cardiovascular, metabolic, respiratory, transplantation and immunology therapeutic areas. Demonstrated success in driving measurable value as a key scientific interface and resource. Adeptly administers the medical affairs function, leveraging extensive pharmaceutical industry experience and a robust clinical hospital background to deliver tangible results. Excels in navigating innovative, dynamic environments and developing/executing medical strategies aligned with corporate objectives. Articulate communicator with superior interpersonal skills; achieves deep levels of engagement with diverse healthcare stakeholders. Rapidly able to pivot, redefine strategies, establish new priorities, and rally team behind complex missions. Skillfully builds and leverages cross-functionally partnerships to drive medical affairs strategy.CORE COMPETENCIESTeam Leadership Direction Regulatory Policy Compliance Training MentoringCross-Functional Collaboration Expense Administration Budget Adherence Presentation DeliveryKOL Engagement Strategies Technology Field Medical Operations Scientific Information Accessibility OptimizationPROFESSIONAL OVERVIEWREGENERON PHARMACEUTICALS 2016-presentAssociate Director, Ophthalmology Field Medical LiaisonStrategically leveraged Pharmaspectra as an early adopter to create influence mapping and engagement plans for 50 key retina specialists in 9 states for Eylea (aflibercept 2 mg) and Eylea HD (aflibercept 8 mg). As an experienced user allowed flexibility to accommodate territory modifications and customer segmentation changes.Headed the Field Medical Retinopathy of Prematurity (ROP) strategy by partnering with clinical, developing a focused scientific expert plan and leading internal training. Responsible for updating and leading ROP training for new hires.Served as the Field Medical Team lead for the IIS program by strongly supporting IIS protocol submissions, action plans and training tutorials.Elevated the FMT congress report platform by redesigning the template for distribution to the national Ophthalmology team.Piloted the Research Hive research tool, presented poster at the Global medical Affairs meeting and provided summary to EVP of R&DResponsible for updating all Ophthalmology slide materials in Veeva Vault together with Medical Information and MRCChampioned the DEI initiative and facilitated meeting with the National Medical association (NMA) executive committee and Regeneron Medical Affairs and patient advocacy division to partner on patient specific initiatives. Ophthalmology representative to create cross therapeutic area Regeneron DEI slide materials.Continue to strive to achieve FM excellence by attending MSL National meeting and networking with medical liaisons across the country and recent completion of the Dale Carnegie High Impact Presentation Course.GILEAD SCIENCES 2009 - 2016Regional Scientific Associate Director, Cardiovascular DivisionCultivated, sustained, and extended critical relationships with over 50 Key Opinion Leaders and speakers in the Cardiovascular, EP, and Endocrine communities.Integral in supporting national product strategies by tailoring scientific product information to meet medical community needs.Facilitated scientific exchange in role as a scientific/medical resource to healthcare professionals.Supported clinical research/development and medical affairs research by identifying and recommending investigators and the ISR process.Enhanced effectiveness of key field-driven activities by contacting investigators and speakers regarding patient retention issues and clinical data updates.Coordinated bimonthly journal club and guest speaker discussions for the Medical Affairs CV Team as Lead of the Medical Literature Evaluation Committee. Served successful five-year tenure as Content Development Team Lead.Spearheaded field medical activities at AHA, ACC, ESC, and CM meetings.Instrumental in driving staff performance as Onboarding Partner for new hires and by leading sales and MSL training. Served as Moderator at regional speaker training and scientific advisory meetings.Fundamental in supporting on-time project delivery and adherence to quality standards.Select AchievementsWorked with compounds in the pre commercialization phase (i.e. eleclazine) by networking with Opinion Leaders in the area of rare genetic arrhythmia disorders. Facilitated participation in phase 2/3 trials, leading to meeting enrollment metrics.Enabled distribution of cutting-edge information to the Medical Affairs CV Team by introducing a high-visibility monthly literature distribution document.Improved knowledge sharing by proactively establishing a medical literature warehousing system to store/retrieve pertinent literature.Presented concepts of the Literature Team, encompassing all therapeutic areas, at national Gilead meetings; presentation content is currently utilized company wide as part of the training process.Served as Therapeutic Lead for the TERISA trial; partnered with the clinical team on strategic planning, including study metrics, protocol education, communication, and publication planning.Introduced a MSL mentor/preceptorship program with a clinical cardiologist, specializing in IHD, leading to three MSL rotations.NOVARTIS PHARMACEUTICALS 2001 - 2009Regional Scientific Associate Director, Cardiovascular/Metabolic DivisionDisseminated medical information regarding specific disease states and Novartis products.Facilitated development of value-added programs, pharmacoeconomic information, and managed care initiatives as an internal and external resource.Ensured effective communication and transparency, serving as a conduit for external and internal research projects and proposals.Played an active role in sales representative training and development, including the creation of educational materials.Select AchievementsServed as a key driver of US Medical Clinical Development Plan support.Held multiple roles of leadership, including Upstate NY FOCUS Team Lead, entailing oversight of all therapeutic area MSLs and CRAs in the region; CAD/Hypertension Training Project Lead, involving training teleconference development; and National Team Lead regarding the role of prorenin/renin receptors.Coordinated collaboration within Scientific Operations and ICRO to screen and create a network of research sites.Education Coordinator for the Renin Inhibitor team (RIST); strategically developed annual education plans; secured speakers for national meetings; completed training materials for Tekturna; collaborated with Managed Care Markets to create Medication Therapeutic Monitoring (MTM) database for field testing and feedback for distribution to the MM KOLs .Lead of Hot Topics for the Northeast; fostered a peer learning environment for colleagues.Orchestrated grass roots effort to drive change in the area of racial and ethnic disparities in Western NY by sponsoring speakers for the Black Cardiologists (ABC) meeting.Previous RolesMedical Information Scientist, Respiratory Medicine, Astra Zeneca Pharmaceuticals Medical Liaison, Cardiovascular, Endocrine, Neurology and Psychiatry, Parke-Davis Division of Warner-Lambert Company Clinical Coordinator, Solid Organ Transplantation and Immunology, Nutrition Support, Critical Care, Buffalo General Hospital Director, Drug Information and Adverse Drug Reaction Reporting, Buffalo General HospitalTEACHING EXPERIENCEResidency Preceptor, BUFFALO GENERAL HOSPITAL 1988 - 1998Preceptor for Clinical and General Hospital Pharmacy Residents.Clinical Assistant Professor, STATE UNIVERSITY OF NEW YORK AT BUFFALO 1991 - 1998Preceptor for pharmacy students in their undergraduate pharmacy clerkship program (PHM 495).Doctor of pharmacy program clerkship selective rotation (PHM 630).Faculty Advisor, STATE UNIVERSITY OF NEW YORK AT BUFFALO 1991 - 1998Doctor of Pharmacy ProgramLecturer, UNIVERSITY OF NEW YORK AT BUFFALO 1989 - 1991Pharmacology and Therapeutic - Asthma - (PHM 492)Pharmacology and Therapeutics - Nutrition - (PHM 511)Lecturer, STATE UNIVERSITY OF NEW YORK AT BUFFALO 1989 - 1991School of NursingEDUCATION & PROFESSIONAL DEVELOPMENTDoctor of Pharmacy, School of Pharmacy, State University of New York at Buffalo, Buffalo, NYBachelor of Science in Pharmacy, School of Pharmacy, State University of New York at Buffalo, Buffalo, NYASHP Accredited Residency, Buffalo General Hospital, Buffalo, NYCertifications: Pharmacotherapy Specialist #297142Licensure: New York State #036009-1PUBLICATIONSAbstract. Cost-effective management of anemia in endstage renal disease patients on hemodialysis: a multidisciplinary approach. Wong T, Sridhar NR, Kohli RK, LoTempio LA, Ludwig EA. Pharmacotherapy 1998; 18(12):445.LoTempio L. Chapter 12. Immunosuppression in Kidney and Kidney/Pancreas Transplantation. Handbook of Kidney and Pancreas Transplantation, R.G. Landes Co., Austin, TX, 1998.Cerasa LA, Bertino Jr. JS, Ludwig EA, Savliwala M, Middleton Jr E, Slaughter RL: The effects of atenolol on the pharmacokinetics of theophylline. Br J Clin Pharmacol. 1988; 26:1-3.Reviewer Nutritional Support of the shock patient. Critical Care Nursing Clinics of North America 1990, vol 2. W.B. Saunders Co., Philadelphia, PA.POSTERS / PRESENTATIONSSpeaker. Pharmacotherapy of the ESRD patient. Review course for dialysis nurses. Buffalo General Hospital, Buffalo, NY. June 14, 1998.Best Poster Award, ACCP Meeting 1998, Phoenix, AZ. Cost-effective management of anemia in endstage renal disease patients on hemodialysis: a multidisciplinary approach. Wong T, Sridhar NR, Kohli RK, LoTempio LA, Ludwig EA.Speaker. Devices for Delivering Dry Powders and Tonics in Asthma Management. The Fourth Annual Asthma Environmental Exposure Conference. Buffalo Hyatt, Buffalo, NY. May 9, 1998.Speaker. Pharmacotherapy of Transplantation. ACPE Program for Pharmacists in Western New York. Buffalo Genera l Hospital, Buffalo, NY. February 7 and 14, 1998.Speaker. Immunosuppression in Transplantation. The Transplant Experience: Current Practices in Western New York. Buffalo General Hospital Nursing Symposium, Buffalo, NY, October 29, 1997 and January 21, 1998.Speaker: New Drug Treatments and Prospects for Anti-Asthma drugs. The Focus on Western New York Respiratory Health Conference on Asthma. Buffalo Hyatt, Buffalo, NY. April 26, 1997.Poster. Adverse Drug Reaction Reporting at the Buffalo General Hospital. Retrospective vs. Prospective Reporting. New York State Council of Health Systems Pharmacist Meeting, Buffalo, NY, May 1997.Speaker: Western New York Nursing Home Consultants. Enteral Nutrition in the Elderly. Daffodils Restaurant, Buffalo, NY. August 1993.Poster: Cholesterol Monitoring Program in Renal Transplant Recipients. New York State Council of Hospital Pharmacist Meeting, Lake George, NY, 1992.Poster: Clinical Experience with Impact and Isotein in Critically Ill Surgical Patients. New York State Council of Hospital Pharmacist Meeting, Lake George, NY, 1990.Conversion to 24hour Supply Automated Compounding System for Parenteral Hyperalimentation. Buffalo General Hospital, Buffalo, NY. Public Service Announcement, Sponsored by the Buffalo General Foundation. Using Medication Safely in the Elderly. 1990.Speaker. Food and Drug Interactions. Symposium sponsored by Nursing Education, Sisters of Charity Hospital, and Continuing Nurse Education. 1989.